Evanium Healthcare GmbH
SME
Evanium Healthcare GmbH
Description
Evanium Healthcare develops consumer health solutions based on secondary plant compounds for the pharmaceutical industry as well as the food sector.
In addition to a platform technology for increasing the solubility of flavonoids, this also includes branded ingredients and fully developed product solutions, especially for the private label sector. The current focus here is primarily on supporting liver function and the nervous system.
In addition to a platform technology for increasing the solubility of flavonoids, this also includes branded ingredients and fully developed product solutions, especially for the private label sector. The current focus here is primarily on supporting liver function and the nervous system.
Evanium Healthcare GmbH
Address
Am Biopark 13 93053 Regensburg Deutschland
93053 Regensburg, Germany
93053 Regensburg, Germany
Contact
kontakt@evanium.de
Description
Evanium Healthcare develops consumer health solutions based on secondary plant compounds for the pharmaceutical industry as well as the food sector.
In addition to a platform technology for increasing the solubility of flavonoids, this also includes branded ingredients and fully developed product solutions, especially for the private label sector. The current focus here is primarily on supporting liver function and the nervous system.
In addition to a platform technology for increasing the solubility of flavonoids, this also includes branded ingredients and fully developed product solutions, especially for the private label sector. The current focus here is primarily on supporting liver function and the nervous system.
Matchmaking
Connect with Evanium Healthcare GmbH
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways